A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics

Abstract Peptides have great potential as therapeutic agents, however, their clinic applications are severely hampered by their instability and short circulation half-life. Zero-order release carriers could not only extend the circulation lifetime of peptides, but also maintain the plasma drug level...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ya-Nan Zhao, Xiaoyu Xu, Na Wen, Rui Song, Qingbin Meng, Ying Guan, Siqi Cheng, Danni Cao, Yansheng Dong, Jiankun Qie, Keliang Liu, Yongjun Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a9bf00e765dd4c13b15512e8f3dd6631
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9bf00e765dd4c13b15512e8f3dd6631
record_format dspace
spelling oai:doaj.org-article:a9bf00e765dd4c13b15512e8f3dd66312021-12-02T16:07:57ZA Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics10.1038/s41598-017-05898-62045-2322https://doaj.org/article/a9bf00e765dd4c13b15512e8f3dd66312017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05898-6https://doaj.org/toc/2045-2322Abstract Peptides have great potential as therapeutic agents, however, their clinic applications are severely hampered by their instability and short circulation half-life. Zero-order release carriers could not only extend the circulation lifetime of peptides, but also maintain the plasma drug level constant, and thus maximize their therapeutic efficacy and minimize their toxic effect. Here using PEGylated salmon calcitonin (PEG-sCT)/tannic acid (TA) film as an example, we demonstrated that hydrogen-bonded layer-by-layer films of a PEGylated peptide and a polyphenol could be a platform for zero-order peptide release. The films were fabricated under mild conditions. The second component, TA, is a natural product and presents potential therapeutic activities itself. Unlike common carriers, the new carrier releases the peptide via gradual disintegration of the film because of its dynamic nature. The release of PEG-sCT follows a perfect zero-order kinetics without initial burst release. In addition the release rate could be tuned via external stimuli, such as pH and temperature. When implanted in rats, the films could remain the plasma level of PEG-sCT constant over an extended period. Accordingly, the serum calcium level was reduced and maintained constant over the same period, suggesting an improved therapeutic efficacy of the released drug.Ya-Nan ZhaoXiaoyu XuNa WenRui SongQingbin MengYing GuanSiqi ChengDanni CaoYansheng DongJiankun QieKeliang LiuYongjun ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ya-Nan Zhao
Xiaoyu Xu
Na Wen
Rui Song
Qingbin Meng
Ying Guan
Siqi Cheng
Danni Cao
Yansheng Dong
Jiankun Qie
Keliang Liu
Yongjun Zhang
A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
description Abstract Peptides have great potential as therapeutic agents, however, their clinic applications are severely hampered by their instability and short circulation half-life. Zero-order release carriers could not only extend the circulation lifetime of peptides, but also maintain the plasma drug level constant, and thus maximize their therapeutic efficacy and minimize their toxic effect. Here using PEGylated salmon calcitonin (PEG-sCT)/tannic acid (TA) film as an example, we demonstrated that hydrogen-bonded layer-by-layer films of a PEGylated peptide and a polyphenol could be a platform for zero-order peptide release. The films were fabricated under mild conditions. The second component, TA, is a natural product and presents potential therapeutic activities itself. Unlike common carriers, the new carrier releases the peptide via gradual disintegration of the film because of its dynamic nature. The release of PEG-sCT follows a perfect zero-order kinetics without initial burst release. In addition the release rate could be tuned via external stimuli, such as pH and temperature. When implanted in rats, the films could remain the plasma level of PEG-sCT constant over an extended period. Accordingly, the serum calcium level was reduced and maintained constant over the same period, suggesting an improved therapeutic efficacy of the released drug.
format article
author Ya-Nan Zhao
Xiaoyu Xu
Na Wen
Rui Song
Qingbin Meng
Ying Guan
Siqi Cheng
Danni Cao
Yansheng Dong
Jiankun Qie
Keliang Liu
Yongjun Zhang
author_facet Ya-Nan Zhao
Xiaoyu Xu
Na Wen
Rui Song
Qingbin Meng
Ying Guan
Siqi Cheng
Danni Cao
Yansheng Dong
Jiankun Qie
Keliang Liu
Yongjun Zhang
author_sort Ya-Nan Zhao
title A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
title_short A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
title_full A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
title_fullStr A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
title_full_unstemmed A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
title_sort drug carrier for sustained zero-order release of peptide therapeutics
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a9bf00e765dd4c13b15512e8f3dd6631
work_keys_str_mv AT yananzhao adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT xiaoyuxu adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT nawen adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT ruisong adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT qingbinmeng adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yingguan adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT siqicheng adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT dannicao adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yanshengdong adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT jiankunqie adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT keliangliu adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yongjunzhang adrugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yananzhao drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT xiaoyuxu drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT nawen drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT ruisong drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT qingbinmeng drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yingguan drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT siqicheng drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT dannicao drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yanshengdong drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT jiankunqie drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT keliangliu drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
AT yongjunzhang drugcarrierforsustainedzeroorderreleaseofpeptidetherapeutics
_version_ 1718384677468766208